Cornerstone Capital Management Holdings’s Novavax NVAX Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,335	Closed	-$54K	–	1392
2016 Q3	$54K	Sell	1,335 -187	-12%	-$24.1K	﹤0.01%	1284
2016 Q2	$221K	Buy	1,522 +470	+45%	+$53.9K	﹤0.01%	1187
2016 Q1	$109K	Sell	1,052 -790	-43%	-$84.7K	﹤0.01%	1306
2015 Q4	$309K	Sell	1,842 -408	-18%	-$62.8K	﹤0.01%	1130
2015 Q3	$318K	Buy	2,250 +420	+23%	+$94.2K	﹤0.01%	1123
2015 Q2	$408K	Buy	1,830 +715	+64%	+$126K	﹤0.01%	1044
2015 Q1	$184K	Buy	1,115 +450	+68%	+$73.1K	﹤0.01%	1195
2014 Q4	$79K	Buy	665 +330	+99%	+$34.5K	﹤0.01%	1184
2014 Q3	$28K	Buy	+335	New	+$30.3K	﹤0.01%	1232

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

QIM

Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Capital Management Holdings's NVAX Position: Q4 2016 in Review

Cornerstone Capital Management Holdings sold out of Novavax (NVAX) in Q4 2016, closing a stake of 1,335 shares — an estimated $54K sold.

Cornerstone Capital Management Holdings first reported a position in NVAX in Q3 2014 and held it in 9 quarters. The position peaked at $408K in Q2 2015. 142 funds tracked by Wall St. Rank hold NVAX as of Q4 2016.

Cornerstone Capital Management Holdings reported no remaining Novavax position as of Q4 2016 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 1,335 Novavax shares in Q4 2016, an estimated $54K.
Cornerstone Capital Management Holdings first reported a position in Novavax in Q3 2014 and held it in 9 quarters.
Cornerstone Capital Management Holdings's Novavax position peaked at $408K in Q2 2015.
142 funds tracked by Wall St. Rank held Novavax as of Q4 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.